Bank Of America Corp Eq Rx, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.61 - $1.96 $3.17 Million - $3.86 Million	-1,969,335 Reduced 53.06%	1,742,133 $3.24 Million
Q1 2023 May 12, 2023	SELL	$1.8 - $2.83 $424,983 - $668,168	-236,102 Reduced 5.98%	3,711,468 $7.2 Million
Q4 2022 Feb 10, 2023	BUY	$2.05 - $5.5 $6.68 Million - $17.9 Million	3,256,947 Added 471.6%	3,947,570 $9.71 Million
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $314,512 - $2 Million	334,588 Added 93.98%	690,623 $3.42 Million
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.69 $725,443 - $1.29 Million	226,701 Added 175.28%	356,035 $1.67 Million
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $362,135 - $955,778	129,334 New	129,334 $534,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.